We've seen headlines that telehealth went up 60X during the pandemic year relative to 2019 - here.
Here's another one. Despite Medicare notoriously raising Part B premiums by 15% for 2022 - and blaming half the rise of "Aduhelm," the Alzheimer biological with nearly no sales so far - actual Part B payments fell 14% or $14B in CY2020.
In a quirky and obscure corny of the Medicare fee schedule, I noted that glaucoma screening tests fell 50% in 2020 - from 100 in 2019 to 50 in 2020. Here. Spinal taps (62270) fell by 2/3 (from about 80,000 to about 25,000).